Uppsala, Sweden, 1st October 2014 – Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, announces the launch of the new Biotage® Extrahera™, an automated system for the processing of Supported Liquid Extraction (SLE) and Solid Phase Extraction (SPE) methods in both plate and column formats – making the system a flexible option for a wide variety of analytical laboratories.
Biotage® Extrahera™ is a compact eight channel automation system that can handle 96 & 48 fixed well plate formats and 1 mL, 3 mL or 6 mL columns. The instrument has been designed for speed and flexibility and is capable of processing a complete 96-well plate SPE method in less than 30 minutes. The system comes pre-loaded with Biotage SPE and SLE methods for plates and columns, while new methods can be created in minutes; using the feature rich software, operators are able to just press “Start” and walk away.
By automating SPE or SLE methods the Biotage® Extrahera™ removes workflow bottlenecks in the laboratory; the higher throughput lowers the cost per sample of analysis and enables skilled analysts to be redeployed to other, more demanding tasks, such as data analysis. Automation also ensures that samples are prepared identically every time, regardless of the sample matrix, improving accuracy and precision of results.
“Sample preparation can be a laborious, time consuming process - implementing Biotage® Extrahera™ ensures that samples can be being generated to feed an MS system as fast as the extraction method permits and as fast as an end user can provide suitable samples for extraction” says Paul Roberts, Analytical Product Manager, Biotage.
Biotage® Extrahera™ utilizes a minimum of moving parts with easily accessible consumables and has been designed to minimize any potential cross contamination. Using positive pressure during processing provides more control and uniformity of flows across multiple columns and wells. The enclosed working area also ensures operator safety and reduces their exposure to solvents and hazardous compounds.
For further information visit www.biotage.com or call: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 422 28 1233, other areas please call +46 18 56 57 10.
For further press information from Biotage please contact: James Churchill, Marketing Communications, Biotage GB Ltd. Distribution Way, Dyffryn Business Park, Ystrad Mynach, Hengoed, Wales CF82 7TS United Kingdom, Tel: +44 (0)1443 811 849 Mobile: +44(0)7875484778 Email: email@example.com
About Biotage Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 290 employees with sales of 444.6 MSEK in 2013. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com
White Paper: Reduce Solvent Use by 50%
Perfecting Your Mass Spectrometer Parameters
Sample Preparation Strategies for Urine Panels with 50 Drugs
Biotage Synthesizer Peer-reviewed Literature
How to Identify Compounds in a Mass Spectrum